IL-33 is known to contribute to AHR since animal studies demonstrated that intranasally administered IL-33 results in an AHR-association with eosinophilia, goblet cell hyperplasia, and accumulation of IL-4, −5 and −13 in the lungs [43,44]. This evidence concerns the gene IL4 and Increased total eosinophil count.